Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-22 to 2023-06-13
Current total value of award: $107827.72
Description: 4561041883!KRYSTEXXA 8 MG/ML VIALML